RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed the RE-LY Trial and a Cluster Randomised Trial to Assess the Effect of a Knowledge Translation Intervention on Patient Outcomes
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed the RE-LY Trial and a Cluster Randomised Trial to Assess the Effect of a Knowledge Translation Intervention on Patient Outcomes
The purposes of this study are:
Inclusion criteria:
Participation in RE-LY, requires long term anticoagulation, provides written informed consent
Exclusion criteria:
Permanent discontinuation of dabigatran during RE-LY
Sao Jose Do Riio Preto, Brazil
Saint George-de-Beauce, Quebec, Canada
Haerbin, China
Plzen-Bory, Czechia
Besle Sur Vilaine, France
Grenoble Cédex 9, France
Le Mesnil En Valée, France
Kalamaria-Thessaloniki, Greece
Voula - Athens, Greece
Ahmedabad-52, India
Kerala, India
Nagpur-12, India
Nordbyhagen, Norway
Ermita Manila, Philippines
Cheonan-si, South Korea
County Armagh, United Kingdom